Bromidotricarbon-yl[2-(pyridin-2-yl-κN)-5-p-tolyl-1,3,4-oxadiazole-κN]rhenium(I) dichloro-methane monosolvate.

ABSTRACT: In the title compound, [ReBr(C(14)H(11)N(3)O)(CO)(3)]·CH(2)Cl(2), the coordination geometry of the Re(I) atom is a distorted ReC(3)N(2)Br octa-hedron with the carbonyl C atoms in a fac arrangement. Within the 2-(pyridin-2-yl)-5-p-tolyl-1,3,4-oxadiazole ligand, the dihedral angles between the oxadiazole ring and the pyridine (py) and benzene (bz) rings are 1.7 (2) and 7.1 (2)°, respectively, and the dihedral angle between the py and bz rings is 5.5 (2)°. In the crystal, aromatic π-π stacking between the oxadiazole rings of adjacent mol-ecules [centroid-centroid separation = 3.465 (3) Å] is seen.

SUBMITTER: Shi LF 

PROVIDER: S-EPMC3050244 | biostudies-literature | 2010 Dec

REPOSITORIES: biostudies-literature